You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 29 No. 1, July 1973 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (81)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

THR (Lopremone): Psychobiological Responses of Normal Women

I. Subjective Experiences

Ian C. Wilson, MB, DPM; Arthur J. Prange, Jr., MD; Patricio P. Lara, MD; Lacoe B. Alltop, MSPH; Rachel A. Stikeleather, RN; Morris A. Lipton, PhD, MD

Arch Gen Psychiatry. 1973;29(1):15-21.


Abstract



Ten normal women were injected intravenously with lopremone (thyrotropin releasing hormone) and saline given one to four weeks apart in a double-blind study. After saline, somatic symptoms and mental changes were negligible. After lopremone, subjects experienced a variety of somatic symptoms, usually within a few minutes of injection.

Later they experienced relaxation, mild euphoria, and a sense of increased energy. Since correlation analyses showed that intensity of euphoria was not related to frequency of side-effects and was negatively related to magnitude of thyrotropin (thyroid stimulating hormone, TSH) response, euphoria presumably did not arise solely from suggestion or from thyroid stimulation.



Author Affiliations



Chapel Hill, NC

From the Department of Psychiatry, Medical School and the Biological Sciences Research Center, University of North Carolina, Chapel Hill (Drs. Prange and Lipton), and the Division of Research, North Carolina Health Department, Raleigh, NC (Drs. Wilson, Lara, Alltop, and Stikeleather).


Footnotes



Accepted for publication April 30, 1973.

Reprint requests to the Department of Psychiatry, University of North Carolina at Chapel Hill, NC 27514 (Dr. Wilson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Behavioral and Endocrine Responses of Schizophrenic Patients to TRH (Protirelin)
Prange et al.
Arch Gen Psychiatry 1979;36:1086-1093.
ABSTRACT  

Behavioral Effects of Protirelin in Schizophrenia
Inanaga et al.
Arch Gen Psychiatry 1978;35:1011-1014.
ABSTRACT  

Angiotensin injected into the neostriatum after learning disrupts retention performance
Morgan and Routtenberg
Science 1977;196:87-89.
ABSTRACT  

Protirelin (TRH) in Depression
Hollister et al.
Arch Gen Psychiatry 1974;31:468-470.
ABSTRACT  

Thyrotropin-Releasing Hormone: Regional Distribution in Rat Brain
Winokur and Utiger
Science 1974;185:265-267.
ABSTRACT  

Thyrotropin-Releasing Hormone in Specific Nuclei of Rat Brain
Brownstein et al.
Science 1974;185:267-269.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.